2009
DOI: 10.1007/s11094-009-0300-5
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and antimicrobial activity of 2-phenyl-3-{1-cyclopropyl-6-fluoro-7-[4-methylpiperazin-1-yl]-4-quinolone}carboxamido-3-thiazolidin-4-ones

Abstract: The title compounds VIa -j have been prepared from the lead molecule 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid I. The lead molecule was converted to hydrazide III via acid chloride II, which on reaction with different substituted aromatic aldehydes a -j afforded Schiff base, and on further structural variation of the Schiff base furnished the final compounds VIa -j (Scheme I).The synthesized compounds were tested for their antibacterial and antifungal activity (MIC) in vitro … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 16 publications
0
3
0
Order By: Relevance
“…The resultant MICs for the antimicrobial effect of complexes 1-3 demonstrate that they are powerfully active, similarly to other copper(II) compounds (Patel and Patel, 2009;Despaigne et al, 2012;Recio Despaigne et al, 2012;Patel and Patidar, 2014;Mehta et al, 2015). In addition, the MIC of these complexes in g mL -1 (1.86 to 10.06) embraces several drugs such as Gentamincin and Pleuromutilin derivatives which have shown inhibition against S. aureus and E. coli within the range of 0.5 to 64  g mL -1 (Islambulchilar et al, 2011;Shang et al, 2014).…”
Section: Pathogenic Fungi and Bacteriamentioning
confidence: 94%
“…The resultant MICs for the antimicrobial effect of complexes 1-3 demonstrate that they are powerfully active, similarly to other copper(II) compounds (Patel and Patel, 2009;Despaigne et al, 2012;Recio Despaigne et al, 2012;Patel and Patidar, 2014;Mehta et al, 2015). In addition, the MIC of these complexes in g mL -1 (1.86 to 10.06) embraces several drugs such as Gentamincin and Pleuromutilin derivatives which have shown inhibition against S. aureus and E. coli within the range of 0.5 to 64  g mL -1 (Islambulchilar et al, 2011;Shang et al, 2014).…”
Section: Pathogenic Fungi and Bacteriamentioning
confidence: 94%
“…The resultant MICs for the antimicrobial effect of complexes 1-3 demonstrate that they are powerfully active, similarly to other copper(II) compounds (Patel and Patel, 2009;Despaigne et al, 2012;Recio Despaigne et al, 2012;Patel and Patidar, 2014;Mehta et al, 2015). In addition, the MIC of these complexes in g mL -1 (1.86 to 10.06) embraces several drugs such as Gentamincin and Pleuromutilin derivatives which have shown inhibition against S. aureus and E. coli within the range of 0.5 to 64  g mL -1 (Islambulchilar et al, 2011;Shang et al, 2014).…”
Section: Pathogenic Fungi and Bacteriamentioning
confidence: 94%
“…Moreover, 4-thiazolidinone and its derivatives have considerable attention for the last decades due to their pharmacological potential. These derivatives are known to acquire several promising chemotherapeutical activities such as antihistaminic [15], anti-inflammatory [16], hypolipidaemic [17], antimicrobial [18], anticonvulsant and antipsychotic [19], antimalarial [20], and anti-cancer [21] activities. Numerous drugs containing thiazole or 4-thiazolidinone moieties in their structure used in broad range in the pharmaceutical market such as Niridazole, Abafungin, Fanetinole, Ralitoline and Etozoline (Fig.…”
Section: Introductionmentioning
confidence: 99%